RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.360
+0.020 (1.49%)
At close: Jun 11, 2025, 4:00 PM
1.360
0.00 (0.00%)
After-hours: Jun 11, 2025, 6:21 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $49.74 million as of June 11, 2025. Its market cap has increased by 53.82% in one year.
Market Cap
49.74M
Enterprise Value
34.71M
1-Year Change
53.82%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $49.74M, a decrease of -27.54%. That is a compound annual growth rate of -8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 49.01M | 58.28% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |